BRVE — Braveheart Bio
Median target
$46.5
calls from the last 12 months
Implied return
+67.8%
median target vs. price
Coverage
5 analysts · 6 calls
updated in the last 12 months
Consensus
5/0/0+5 net
Buy / Hold / Sell
Which analysts are behind BRVE's consensus?
See every current rating, price target and the analysts' track records for Braveheart Bio — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 5 analysts with calls on BRVE updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
BRVE elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-07 | Insiders | Forbion Growth Opportunities F +310% owner | Insider purchase | 1.9M sh @ $18.00 | $34.6M |
| 2026-08-07 | Insiders | Forbion Growth Opportunities F +310% owner | Insider purchase | 1.7M sh @ $18.00 | $30.2M |
| 2026-08-07 | Insiders | Chimovits ErezDirector | Insider purchase | 1.7M sh @ $18.00 | $30.0M |
| 2026-08-07 | Insiders | Orbimed Advisors Llc +2Director | Insider purchase | 1.7M sh @ $18.00 | $30.0M |
| 2026-08-07 | Insiders | Ah Bio Fund Iv, L.P. +310% owner | Insider purchase | 1.1M sh @ $18.00 | $19.8M |
| 2026-08-07 | Insiders | Orbimed Advisors Llc +2Director | Insider purchase | 273.3K sh @ $18.00 | $4.9M |
| 2026-08-07 | Insiders | Chimovits ErezDirector | Insider purchase | 273.3K sh @ $18.00 | $4.9M |
| 2026-08-07 | Insiders | Murdoch TravisCEO and President | Insider purchase | 83.3K sh @ $18.00 | $1.5M |
| 2026-08-07 | Insiders | Viehbacher ChristopherDirector | Insider purchase | 83.3K sh @ $18.00 | $1.5M |
| 2026-08-07 | Insiders | Lubner David CharlesDirector | Insider purchase | 55.6K sh @ $18.00 | $1000K |
More: insider activity · executive branch · trending